Revvity (0KHE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Revvity (0KHE) has a cash flow conversion efficiency ratio of 0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($183.28 Million) by net assets ($7.25 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Revvity - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Revvity's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Revvity Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Revvity ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aegon NV
AS:AGN
|
0.132x |
|
Guidewire Software Inc
NYSE:GWRE
|
0.074x |
|
Danone PK
OTCQX:DANOY
|
0.063x |
|
Max Healthcare Institute Limited
NSE:MAXHEALTH
|
0.012x |
|
EastGroup Properties Inc
NYSE:EGP
|
0.019x |
|
GEA GROUP
XETRA:G1A
|
0.222x |
|
Abivax SA American Depositary Shares
NASDAQ:ABVX
|
-0.051x |
|
Universal Health Services Inc
NYSE:UHS
|
0.052x |
Annual Cash Flow Conversion Efficiency for Revvity (1989–2025)
The table below shows the annual cash flow conversion efficiency of Revvity from 1989 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.25 Billion | $581.78 Million | 0.080x | -2.09% |
| 2024-12-31 | $7.67 Billion | $628.30 Million | 0.082x | 0.00% |
| 2024-12-29 | $7.67 Billion | $628.30 Million | 0.082x | +606.86% |
| 2023-12-31 | $7.87 Billion | $91.27 Million | 0.012x | -87.41% |
| 2023-01-01 | $7.38 Billion | $679.81 Million | 0.092x | +0.14% |
| 2022-12-31 | $7.39 Billion | $679.81 Million | 0.092x | -53.45% |
| 2022-01-02 | $7.14 Billion | $1.41 Billion | 0.198x | -0.15% |
| 2021-12-31 | $7.13 Billion | $1.41 Billion | 0.198x | -17.16% |
| 2021-01-03 | $3.74 Billion | $892.18 Million | 0.239x | 0.00% |
| 2020-12-31 | $3.74 Billion | $892.18 Million | 0.239x | +84.90% |
| 2019-12-31 | $2.81 Billion | $363.47 Million | 0.129x | 0.00% |
| 2019-12-29 | $2.81 Billion | $363.47 Million | 0.129x | +7.35% |
| 2018-12-31 | $2.58 Billion | $311.04 Million | 0.120x | 0.00% |
| 2018-12-30 | $2.58 Billion | $311.04 Million | 0.120x | +4.42% |
| 2017-12-31 | $2.50 Billion | $288.45 Million | 0.115x | -29.22% |
| 2017-01-01 | $2.15 Billion | $350.62 Million | 0.163x | 0.00% |
| 2016-12-31 | $2.15 Billion | $350.62 Million | 0.163x | +19.68% |
| 2016-01-03 | $2.11 Billion | $287.10 Million | 0.136x | 0.00% |
| 2015-12-31 | $2.11 Billion | $287.10 Million | 0.136x | -1.35% |
| 2014-12-31 | $2.04 Billion | $281.60 Million | 0.138x | 0.00% |
| 2014-12-28 | $2.04 Billion | $281.60 Million | 0.138x | +73.21% |
| 2013-12-31 | $1.99 Billion | $158.59 Million | 0.080x | +0.12% |
| 2013-12-29 | $1.99 Billion | $158.59 Million | 0.080x | +1.36% |
| 2012-12-31 | $1.94 Billion | $152.17 Million | 0.078x | 0.00% |
| 2012-12-30 | $1.94 Billion | $152.17 Million | 0.078x | -35.77% |
| 2011-12-31 | $1.84 Billion | $224.87 Million | 0.122x | +43.20% |
| 2010-12-31 | $1.93 Billion | $164.25 Million | 0.085x | -6.58% |
| 2009-12-31 | $1.63 Billion | $148.72 Million | 0.091x | -34.29% |
| 2008-12-31 | $1.57 Billion | $217.84 Million | 0.139x | +6.70% |
| 2007-12-31 | $1.58 Billion | $205.13 Million | 0.130x | +61.21% |
| 2006-12-31 | $1.58 Billion | $127.44 Million | 0.081x | -35.93% |
| 2005-12-31 | $1.65 Billion | $208.09 Million | 0.126x | -8.30% |
| 2004-12-31 | $1.46 Billion | $200.76 Million | 0.137x | +10.76% |
| 2003-12-31 | $1.35 Billion | $167.47 Million | 0.124x | +53.17% |
| 2002-12-31 | $1.25 Billion | $101.50 Million | 0.081x | -10.37% |
| 2001-12-31 | $1.36 Billion | $123.30 Million | 0.090x | -54.75% |
| 2000-12-31 | $728.39 Million | $145.55 Million | 0.200x | -4.96% |
| 1999-12-31 | $550.80 Million | $115.80 Million | 0.210x | +20.74% |
| 1998-12-31 | $399.70 Million | $69.60 Million | 0.174x | +64.27% |
| 1997-12-31 | $328.30 Million | $34.80 Million | 0.106x | -51.74% |
| 1996-12-31 | $365.10 Million | $80.20 Million | 0.220x | -46.34% |
| 1995-12-31 | $366.90 Million | $150.20 Million | 0.409x | +90.13% |
| 1994-12-31 | $445.40 Million | $95.90 Million | 0.215x | -8.29% |
| 1993-12-31 | $477.50 Million | $112.10 Million | 0.235x | -13.00% |
| 1992-12-31 | $473.60 Million | $127.80 Million | 0.270x | +8.74% |
| 1991-12-31 | $420.70 Million | $104.40 Million | 0.248x | -29.01% |
| 1990-12-31 | $369.60 Million | $129.20 Million | 0.350x | +132.82% |
| 1989-12-31 | $349.00 Million | $52.40 Million | 0.150x | -- |
About Revvity
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more